Groundbreaking Study in the Journal of Clinical Investigation Advances Cell Therapy for Huntington's Disease Treatment

Groundbreaking Study in the Journal of Clinical Investigation Advances Cell Therapy for Huntington's Disease Treatment

SHANGHAI, Oct. 20, 2025 /PRNewswire/ -- The research team led by Dr. Yuejun Chen, founder of UniXell Biotech, published online an article titled "3D-Cultured Human Medium Spiny Neurons Achieve Functional Integration into Huntingtin Disease Mouse...

CARsgen Presents Research Results on Satri-cel in The Lancet and at the 2025 ASCO Annual Meeting

CARsgen Presents Research Results on Satri-cel in The Lancet and at the 2025 ASCO Annual Meeting

SHANGHAI, June 2, 2025 /PRNewswire/ -- CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on developing innovative CAR T-cell therapies, announces that the results of the pivotal Phase II clinical trial in China...

JA Solar's Bycium+ Cell Achieves Record-Breaking 748.6mV Open-Circuit Voltage Certified by ISFH

JA Solar's Bycium+ Cell Achieves Record-Breaking 748.6mV Open-Circuit Voltage Certified by ISFH

BEIJING, Dec. 16, 2024 /PRNewswire/ -- JA Solar's Bycium+ cell has achieved a significant breakthrough, having reached a new high in cell efficiency and set a new record with an open-circuit voltage of 748.6mV—the highest in the commercial TOPCon PV...

menu
menu